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A study on the toxic effects of lipopolysaccharide (LPS) of Pasteurella multocida 
type 6:B in mice was conducted. In addition, the immunogenic potential of LPS as 
subunit vaccines was evaluated in mice. Initial studies showed that the purified LPS, 
which contained 0.14% protein as contaminant, had toxic effects in mice even at low 
levels. The mice exhibited toxic effects such as depression and ruffled hair coat after a 
few hours of inoculation and they survived if limited inoculation doses were used. It 
could be speculated that the protection afforded in mice immunised with LPS was not due 
ii 
to the LPS and the protection could be attributed to the contamination of proteins in the 
LPS extracts. 
Protective capacities of whole-cell killed vaccines grown under iron-regulated 
conditions were evaluated. Vaccines made from formalin-killed whole cells of P. 
multocida type 6 :B grown under iron-restricted conditions were found to be superior in 
imparting protection to mice against experimental pasteurellosis than those grown under 
iron-repleted conditions. It could be speculated that some cell-associated antigens 
responsible for protective immtmity were expressed better under iron-limiting conditions. 
The isolation and purification of outer membrane proteins (OMPs) in this study was from 
P. multocida grown under iron-restricted condition where a,a' -dipyridyl was used as the 
iron chelator. 
The extraction of OMP of P. multocida was carried out using Sarkosyl method. 
The final purified OMP was chosen for subsequent purification studies, as it contained 
less LPS and afforded 1 00% protection to immunised mice. The extracts were shown to 
have about 1 2  protein bands when electrophoressed on SDS-PAGE gels in which 33 kD 
and 37 kD proteins appeared as major OMPs of P. multocida with the 87 kD and 1 1 6 kD 
protein bands as next prominent ones. 
Active protection studies of purified proteins obtained after preparative 
electrophoresis llsing Prep Cell, cylindrical and stained gels have shown that proteins 
with MWs 29, 3 3  and 37 kD have the potential as subunit vaccines. Whereas, high MW 
proteins only afTorded up to 60% protection to the immunised mice. However, the 
Immune response of the target and laboratory animals was different as judged by 
iii 
comparative immunoblotting. Almost all the antibodies of mice and cattle antiserum 
reacted to 29, 3 3 ,  37,  52, 7 1 ,  87 and 1 1 6 kD proteins except 33 kD protein for cattle 
antiserum. It showed that the mice immune response is very similar to the cattle .  
Mice immunised with purified 29 kD alone was shown to afford a lower 
protection. When it was excised, electro-eluted then rerun on mini SDS-PAGE, the 29 kD 
protein produced a ladder form of protein bands of MW 29, 37  and 47 kD. It was 
speculated that the 29 kD protein is a monomeric form of the protein H of P. multocida 
and the 37  kD protein is a trimer. Thus, the trimeric form with MW 3 7  kD protein could 
be an attractive vaccine candidate. 
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Suatu kajian mengenai kesan-kesan keracunan lipopolisakarid dari bakteria 
P. multocida jenis 6 :B terhadap tikus telah dilakukan. Selain daripada itu potensi 
LPS yang mempunyai daya pelindungan (immunogenic) sebagai subunit ubat 
pelalian telah dinilai didalam tikus. Diawal kajian menunjukkan bahawa LPS tulin 
dengan kandungan protin 0.14% sebagai bahan sampingan mempunyai kesan-kesan 
keracunan seperti depression dan bulu-bulu yang kusut beberapa jam selepas 
suntikan dan adalah selamat sekiranya suntikan pelalian dilakukan secara 
berperingkat-peringkat. Didalam kajian ini juga adalah dicadangkan bahawa daya 
v 
perlindungan yang diterima oleh tikus yang diberi pelalian LPS,  bukan disebabkan 
perlindungan dari LPS . Perlindungan yang diterima oleh tikus melawan 
pasteurellosis berkemungkinan adalah disebabkan bahan sampingan protin. 
Keupayaan dalam memberi perlindungan oleh ubat pelalian yang terdiri dari 
sel-sel mati bakteria yang tumbuh dibawah keadaan kawalan ion ferum adalah 
dinilai .  Didapati bahawa ubat pelalian yang dibuat daripada sel-sel mati bakteria P. 
multocida yang tumbuh dibawah keadaan kekurangan ion ferum telah 
menyumbang/memberi daya perlindungan yang lebih baik berbanding yang tumbuh 
dalam keadaan yang diperkaya dengan ion ferum. lni menunj ukkan bahawa antigen 
yang terdapat pada sel bakteria dan bertanggungjawab untuk memberi perlindungan 
telah dij anakan/dihasilkan lebih baik dibawah keadaan kekurangan ion ferum. 
Pengasingan dan penulinan protin-protin membran luar (OMPs) didalam kaj ian ini 
telah menggunakan P. multocida yang tumbuh didalam keadaan kekurangan IOn 
ferum dengan a,a' -dipyridyl digunakan sebagai pemerangkap ferum. 
Ekstraksi OMP dari P. multocida dilakukan menggunakan kaedah Sarkosyl .  
Hasil akhir didalam proses penulinan OMP digunakan untuk kaj ian selanjutnya 
memandangkan ianya memberi perlindungan 1 00% terhadap tikus yang diberi 
pelalian dan terdapat kandungan LPS yang rendah. Didalam gel mini SDS-P AGE, 
ekstrak telah menunj ukan terdapat lebih kurang 12 j aluran protin dimana protin­
protin 3 3  kD dan 37 kD merupakan protin utama dalam OMP manakala protin­
protin 87 dan 1 1 6 kD pula prominan. 
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The livestock industry is important in providing high quality protein for the 
population and raw materials for the food processing industry. The ruminant sector 
has registered steady growth largely due to greater participation of government land 
development agencies in cattle and sheep rearing integrated with plantation crops. In 
1 995,  1 5  per cent of the cattle population was raised through integration of cattle with 
plantation crops. In Malaysia, the average annual per capita consumption of both beef 
and mutton continued to increase by 6 .0  and 4. 1 per cent, respectively in 1 985  and 
1 995 .  In terms of market potential, the domestic demand for fresh beef and mutton are 
expected to increase. The total projected demand for beef is 88 ,000 tonnes in 1 995 
and 240,000 tonnes by the year 20 1 0  with per capita consumption for the same years 
being 4.3 kg and 8 .4 kg, respectively (Third National Agricultural Policy, 1 998 -
20 1 0). 
According to the 1 995 livestock statistics compiled by the Department of 
Veterinary Services (DVS), the cattle and buffalo population in Malaysia ranged from 
about 765,000 to 892,000 heads for the last ten-year period (Table 1 ). These animals 
were used more for the provision of meat and milk. The beef consumption in the ten­
year period has increased from 37,442 metric ton in 1 986 to 86,039 metric ton in 1 995 
and the milk production was at an average of 68.27 million liter per year. 
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Table 1 
Cattle and buffalo population and the livestock products in Malaysia: 1986-
1996 reported by Department of Veterinary Services annual report. 
Year Cattle Buffalo Milk (m. liter) Beef consumption (m. tonnes) 
1986 607, 1 80 206,629 53 8 .02 3 7,442 
1987 63 1 ,699 2 1 5,770 608.40 40,571  
1 98 8  640,62 1 2 1 3 , 145 762.73 46,3 8 1  
1 989 661 ,041 2 1 0,061 5 8 1 .72 54,289 
1 990 652,498 1 94,5 1 7  56 1 . 1 8  57,424 
1 99 1  637,663 1 27,850 829.23 63,832 
1 992 654,358  1 22,259 792.23 65,467 
1 993 704,687 1 1 9,853 729.88  70, 1 1 5  
1 994 724,353 1 67,853 535 .65 77,699 
1 995 71 5,279 165,06 1 863 .62 86,039 
Haemorrhagic septicaemia (HS), an acute septicaemic disease principally 
affecting cattle and buffalo, is caused by two serotypes of Pasteurella multocida, viz., 
Asian serotype B :2 and the African serotype E:2 (Heddleston et aI. ,  1 972) 
corresponding to 6:B and 6:E respectively (Namioka and Murata, 1 96 1 ) . The disease 
is characterised by a rapid course, oedematous swelling in the head-throat-brisket 
region, swollen and haemorrhagic lymph nodes and the presence of numerous 
subserous petechial haemorrhages. Haemorrhagic septicaemia is distinctly different 
from other pasteurellosis where Pasteurellae may play only a secondary role. It is a 
specific form of pasteurellosis in cattle and buffaloes, just as typhoid fever and 
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pullorum are specific forms of salmonellosis in man and poultry, respectively. In 
cattle and buffaloes the condition is termed septicaemic pasteurellosis. 
Although there is some reduction in the occurence of the disease due to the 
vaccination programmes, outbreaks of HS still occur at the beginning of the rainy 
season particularly in Asia (Bain et al., 1982a). In many Asian countries, the disease 
has a great socio-economic significance to livestock farmers, particularly the small­
scale subsistence farmers who depend on cattle and buffaloes for their farming 
activities. These animals are used not only for provision of meat and milk but also for 
draught power for agricultural purposes (Bain et al., 1 982b). 
Haemorrhagic septicaemia in Malaysia has been known to occur for more than 
90 years. The disease was first described in 1 900 (Corongean, 1 902). The disease has 
become enzootic in this country and continues to be a problem with the loss of 
susceptible livestock. Although there is no up to date data on losses due to this 
disease, it was estimated that approximately RM l .5 million worth of livestock was 
lost in West Malaysia in 1 966. The Office International Des Epizooties (OIE) 
reported that for the period between 1 992 to Jun 1 997, infection with P. multocida 
was highest in India affecting more than one hundred thousand animals (see Table 2) 
followed by Vietnam (> 1 3,000), Indonesia (>9,000), Myanmar (>3 ,000) and Sri 
Langka (97 1 ) . In Malaysia the number of animal infected with P. multocida during 
that period was 453 animals (OIE Report, 1 997) . 
It has been noted that many outbreaks occur during the monsoon and padi 
planting seasons in all states of Malaysia. Although the reasons for the outbreaks are 
not clear, the inclement weather and stress of work could probably lower the 
4 
resistance of the animals (Chandrasekaran, 1 988). However, outbreaks can still occur 
at any time of the year. 
Haemorrhagic septicaemia in Malaysia is controlled during outbreaks by 
prophylactic vaccination. Despite rigorous vaccination carried out by the DVS in 
1 988, 1 989 and 1 990 involving 1 34,965, 1 1 5 ,9 1 5  and 1 9 1 ,393 animals respectively, 
outbreaks of the disease still occur due to the short falls in vaccination resulting in 4, 
2 1 6  and 1 63 mortalities, respectively. The outbreaks were reported in Alor Gajah 
Melaka, Rembau Negeri Sembilan, Maran and Kuala Nerus in Terengganu as well as 
in a government cattle farm at Ulu Lepar Pahang (DVS Annual Report 1 988/89, DVS 
Annual Report 1 990). The disease was successfully controlled through the use of 
vaccines (oil adjuvant and broth bacterin) produced by the Veterinary Research 
Institute (VRI) and no outbreaks were recorded for the years 1 990 to 1 995. The 
farmers then discontinued the vaccination at the end of 1 995 with the assumption that 
HS was tmder control.  However, in 1 996 HS occurred in Seberang Prai Pulau Pinang 
and Negeri Sembilan at Rembau and Kuala Pilah districts where 1 2  cattle and 22 
buffaloes died. 
At present, the only means of effective control is by vaccination. Although 
considerable reduction in deaths due to this disease had been achieved by 
immunisation with the currently available vaccines, there are still some major 
problems including adverse reactions and other drawbacks encountered with the use 
of the vaccines. Vaccination with killed bacteria is practiced and is sometimes 
effective in controlling clinical disease. However, it is not uncommon for vaccinated 
herds to suffer outbreaks (Adler et al., 1 996). Moreover, immunity is generally 
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serotype specific. Empirically derived live virulent strains have been used as vaccines 
in both poultry and cattle (Derieux, 1 984; Myint et ai., 1 987), but the basis for 
attenuation is not known. It is therefore not surprising that reversion to virulence has 
occasionally occurred (Hofacre, 1 986). 
Three types of vaccines are commonly used in the field to control HS; the 
broth bacterin (BB), alum-precipitated vaccine (APV) and the more popular oil 
adjuvant vaccine (OA V). Broth bacterin is the first vaccine used in this country and 
had afforded protection for up to 3 months in cattle (Thomas, 1 97 1 ). Initially only 
broth bacterin was used as a prophylactic agent against HS in Malaysia. However, 
between 1 965 - 1 966 there were reports of outbreaks of HS among vaccinated 
animals, which was attributed to 'vaccine breakdown' and thus initiated the shift to 
the usage of either APV or OAV. Broth bacterin had been used in Malaysia initially 
but was replaced by APV as animals vaccinated with broth bacterin showed 
symptoms of sc.aphylactic shock reaction within minutes of inoculation. The 
symptoms appeared several hours after vaccination and animals died from post 
vaccination shock if not treated with anti-histamine and adrenaline (Bain et al., 
1982a). Similar incidence of post-vaccmation shock has been reported in many other 
contries (Bain et al., 1 982a) . 
The duration of immunity provided by the vaccine is still a problem. Many 
countries use the OAV, which has been claimed to impart a longer duration of 
immunity for up to a maximum of one-year (Chandrasekaran & Geneidy, 1 994). In 
the countries lIke Sri Lanka, Indonesia and India, annual vaccination with OA V is 
practised, but in Thailand, Malaysia, Vietnam, Cambodia, Myanmar and Philippines, 
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the use APV is preferred because of its ease of production and administration. Alum­
precipitated vaccine provides immunity for up to six months and two injections per 
year were needed. However, the usage of APV has become a problem for the 
countries where more than one enzootic disease exists when more than one vaccine 
cannot be administered simultaneously (Interior, 1 993). The farmers usually do not 
want their cattle or buffaloes to be vaccinated many times (Neramitmansook, 1 993) .  
Although OA V is a more popular vaccme m many countries because it 
induces a much longer immunity i.e up to one year, it is highly viscous and very 
difficult to administer intramuscularly due to its thick consistency. This makes it an 
unpopular product among vaccinators (Bain et ai., 1 982a) .  Improper administration of 
the vaccine also produces local tissue reactions resulting in large, painful and 
persistent subcutaneous swellings. The other major problems associated with the 
current vaccines are breakdown of immunity and lack of consistency in the quality of 
different batch of vaccines. 
To overcome the problems associated with the use of currently available 
vaccines, the quality and effectiveness of vaccine need to be improved. One of the 
strategies to improve the effectiveness is by enhancing the capability of the vaccine to 
enhance protective antibody response. This could be achieved in a number of ways. 
Firstly, the growth conditions of the bacteria could be regulated or manipulated to 
allow the organism to express certain specific immunogens of high quality. Secondly, 
the most-potent immunogens of the organism need to be identified and subunit 
vaccines produced using these immunogens. 
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The experiments carried out 111 this study were designed to achieve the 
following objectives: 
1 .  To determine the minimum moribund dose and the minimum time required for 
immune response in immunised mice. 
2 .  To determine the toxic effects of lipopolysacharide in mice. 
3 .  To identify and purify the most potent immunogens o f  P. multocida type B :6. 
4 .  To evaluate the protective capacities of the killed whole-cells, LPS and OMPs 
of P. multocida type B :6  grown under iron-rich and iron-depleted conditions. 
5 .  To identify the proteins o f  outer membrane origin which are expressed under 
iron-limiting condition. 
